Location History:
- Apex, NC (US) (2016)
- Research Triangle Park, NC (US) (2022)
Company Filing History:
Years Active: 2016-2022
Title: Chad M Kormos: Innovator in Opioid Receptor Antagonists
Introduction
Chad M Kormos is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of pharmacotherapy, particularly in the development of compounds that target opioid receptors. With a total of two patents to his name, Kormos is recognized for his innovative approaches to treating various mental health and addiction disorders.
Latest Patents
Kormos's latest patents include the development of substituted 1,2,3,4-tetrahydroisoquinolines as kappa opioid antagonists. These compounds are described as potent opioid receptor antagonists that can be utilized in pharmacotherapies for treating depression, anxiety, schizophrenia, eating disorders, and addictions to substances such as cocaine, methamphetamine, nicotine, alcohol, and opiates. Additionally, he has patented 1-substituted 4-arylpiperazine as kappa opioid receptor antagonists, providing a detailed formula for these compounds and their potential applications.
Career Highlights
Chad M Kormos is affiliated with the Research Triangle Institute, where he continues to advance his research and development efforts. His work focuses on creating effective pharmaceutical compositions that can significantly improve the quality of life for individuals struggling with addiction and mental health issues.
Collaborations
Kormos has collaborated with notable colleagues in his field, including Frank Ivy Carroll and Scott P Runyon. These partnerships have likely contributed to the innovative nature of his work and the successful development of his patented compounds.
Conclusion
Chad M Kormos stands out as an influential inventor in the realm of opioid receptor antagonists. His contributions to pharmacotherapy are paving the way for new treatments that address critical health challenges.